Cargando…

SAT-491 Severe Hypercalcemia Secondary to Primary Skeletal Sarcoidosis

Introduction: Sarcoidosis is an autoimmune disorder that is characterized by non-caseating granulomas found throughout affected tissues. It has an incidence of 10-12 per 100,000 patients per year (2). Common clinical manifestations of sarcoidosis include hilar adenopathy, abnormally high angiotensin...

Descripción completa

Detalles Bibliográficos
Autores principales: Dbeis, Ammer, Lababidi, Hashem, Allabban, Waseem, Kartoumah, Almutaz, Shahlapour, Mahmood, Horani, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552086/
http://dx.doi.org/10.1210/js.2019-SAT-491
_version_ 1783424521262333952
author Dbeis, Ammer
Lababidi, Hashem
Allabban, Waseem
Kartoumah, Almutaz
Shahlapour, Mahmood
Horani, Mohamad
author_facet Dbeis, Ammer
Lababidi, Hashem
Allabban, Waseem
Kartoumah, Almutaz
Shahlapour, Mahmood
Horani, Mohamad
author_sort Dbeis, Ammer
collection PubMed
description Introduction: Sarcoidosis is an autoimmune disorder that is characterized by non-caseating granulomas found throughout affected tissues. It has an incidence of 10-12 per 100,000 patients per year (2). Common clinical manifestations of sarcoidosis include hilar adenopathy, abnormally high angiotensin-converting enzyme (ACE), abnormally high vitamin D, and respiratory symptoms such as cough. While the lungs are commonly affected by sarcoidosis, extrapulmonary involvement occurs in over 30% of cases of sarcoidosis (1). The incidence of musculoskeletal involvement, specifically, is approximately 14%, however, most cases are asymptomatic (2). Case Presentation: A 79-year-old female with a past medical history of asthma, dementia, CAD, CKD, and HTN presents with asymptomatic hypercalcemia. She was directly admitted for hypercalcemia, AKI, and UTI and was started on Keflex and IV fluid therapy. Endocrinology, rheumatology, oncology, and nephrology were consulted. Over the course of her evaluation, further labs revealed: continued hypercalcemia: with a nadir of 13.5, elevated 1,25 vitamin D with a nadir of 100.0, and elevated ACE levels with a nadir of 125. Phosphorus, magnesium, PTH, and PTHrP levels were all within normal limits. The patient’s only complaint was dry mouth. Repeat physical examinations were stable and within normal limits other than increasing blood pressure, as high 172/70. She was started on dexamethasone to decrease conversion of Vitamin D to 1,25 hydroxyvitamin D. Throughout her stay, the patient had a negative NM parathyroid scan and a negative full body PET-CT. A CT chest w/o contrast revealed nonsp ecific ground-glass opacification with interval resolution of a small pulmonary nodule. Her diagnosis of sarcoidosis was only confirmed with a bone marrow biopsy of her right posterior iliac crest that revealed multiple non-necrotizing granulomas. Discussion: Atypical presentations of illnesses warrant exhaustive diagnostic workup. Although this patient’s laboratory values classically pointed towards a granulomatous process - elevated vitamin D and ACE levels - her diagnostic imaging studies, including full body PET-CT, were negative, steering away from a diagnosis of skeletal sarcoidosis. If it were not for a bone marrow biopsy, this patient would have potentially suffered greatly with the development of cystic bony degeneration and consequences such as fracture needing invasive orthopedic surgical intervention.
format Online
Article
Text
id pubmed-6552086
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65520862019-06-13 SAT-491 Severe Hypercalcemia Secondary to Primary Skeletal Sarcoidosis Dbeis, Ammer Lababidi, Hashem Allabban, Waseem Kartoumah, Almutaz Shahlapour, Mahmood Horani, Mohamad J Endocr Soc Bone and Mineral Metabolism Introduction: Sarcoidosis is an autoimmune disorder that is characterized by non-caseating granulomas found throughout affected tissues. It has an incidence of 10-12 per 100,000 patients per year (2). Common clinical manifestations of sarcoidosis include hilar adenopathy, abnormally high angiotensin-converting enzyme (ACE), abnormally high vitamin D, and respiratory symptoms such as cough. While the lungs are commonly affected by sarcoidosis, extrapulmonary involvement occurs in over 30% of cases of sarcoidosis (1). The incidence of musculoskeletal involvement, specifically, is approximately 14%, however, most cases are asymptomatic (2). Case Presentation: A 79-year-old female with a past medical history of asthma, dementia, CAD, CKD, and HTN presents with asymptomatic hypercalcemia. She was directly admitted for hypercalcemia, AKI, and UTI and was started on Keflex and IV fluid therapy. Endocrinology, rheumatology, oncology, and nephrology were consulted. Over the course of her evaluation, further labs revealed: continued hypercalcemia: with a nadir of 13.5, elevated 1,25 vitamin D with a nadir of 100.0, and elevated ACE levels with a nadir of 125. Phosphorus, magnesium, PTH, and PTHrP levels were all within normal limits. The patient’s only complaint was dry mouth. Repeat physical examinations were stable and within normal limits other than increasing blood pressure, as high 172/70. She was started on dexamethasone to decrease conversion of Vitamin D to 1,25 hydroxyvitamin D. Throughout her stay, the patient had a negative NM parathyroid scan and a negative full body PET-CT. A CT chest w/o contrast revealed nonsp ecific ground-glass opacification with interval resolution of a small pulmonary nodule. Her diagnosis of sarcoidosis was only confirmed with a bone marrow biopsy of her right posterior iliac crest that revealed multiple non-necrotizing granulomas. Discussion: Atypical presentations of illnesses warrant exhaustive diagnostic workup. Although this patient’s laboratory values classically pointed towards a granulomatous process - elevated vitamin D and ACE levels - her diagnostic imaging studies, including full body PET-CT, were negative, steering away from a diagnosis of skeletal sarcoidosis. If it were not for a bone marrow biopsy, this patient would have potentially suffered greatly with the development of cystic bony degeneration and consequences such as fracture needing invasive orthopedic surgical intervention. Endocrine Society 2019-04-30 /pmc/articles/PMC6552086/ http://dx.doi.org/10.1210/js.2019-SAT-491 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Bone and Mineral Metabolism
Dbeis, Ammer
Lababidi, Hashem
Allabban, Waseem
Kartoumah, Almutaz
Shahlapour, Mahmood
Horani, Mohamad
SAT-491 Severe Hypercalcemia Secondary to Primary Skeletal Sarcoidosis
title SAT-491 Severe Hypercalcemia Secondary to Primary Skeletal Sarcoidosis
title_full SAT-491 Severe Hypercalcemia Secondary to Primary Skeletal Sarcoidosis
title_fullStr SAT-491 Severe Hypercalcemia Secondary to Primary Skeletal Sarcoidosis
title_full_unstemmed SAT-491 Severe Hypercalcemia Secondary to Primary Skeletal Sarcoidosis
title_short SAT-491 Severe Hypercalcemia Secondary to Primary Skeletal Sarcoidosis
title_sort sat-491 severe hypercalcemia secondary to primary skeletal sarcoidosis
topic Bone and Mineral Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552086/
http://dx.doi.org/10.1210/js.2019-SAT-491
work_keys_str_mv AT dbeisammer sat491severehypercalcemiasecondarytoprimaryskeletalsarcoidosis
AT lababidihashem sat491severehypercalcemiasecondarytoprimaryskeletalsarcoidosis
AT allabbanwaseem sat491severehypercalcemiasecondarytoprimaryskeletalsarcoidosis
AT kartoumahalmutaz sat491severehypercalcemiasecondarytoprimaryskeletalsarcoidosis
AT shahlapourmahmood sat491severehypercalcemiasecondarytoprimaryskeletalsarcoidosis
AT horanimohamad sat491severehypercalcemiasecondarytoprimaryskeletalsarcoidosis